Belenchia et al. determined the impact of treatment with vitamin D in American children and adolescents with obesity (with 25-hydroxy vitamin D level < 20 ng/mL) on vitamin D levels, insulin secretion and sensitivity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.